8 Recruiting Mesothelioma Phase 2 Clinical Trials
Active phase 2 studies for mesothelioma enrolling across the USA. Verify eligibility and contact site coordinators.
All Mesothelioma studiesPhase 2 Studies for Mesothelioma
🔵 Active, Not Recruiting Phase2
Neoadjuvant Immune Checkpoint Blockade in Resectable Malignant Pleural Mesothelioma
📍 Greenebaum Comprehensive Cancer Center University of Maryland School of Medicine — Baltimore, Maryland
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2
Pleurectomy/Decortication (Neo) Adjuvant Chemotherapy and Intensity Modulated Radiation Therapy to the Pleura in Patients With Locally Advanced Malignant Pleural Mesothelioma
📍 Moffitt Cancer Center — Tampa, Florida
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 / Phase2
Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer
📍 University of California, San Francisco — San Francisco, California
View Study & Checklist ➔ 🟢 Recruiting Phase2
Olaparib in Patients With HRD Malignant Mesothelioma
📍 University of Chicago Medical Center — Chicago, Illinois
View Study & Checklist ➔ 🟢 Recruiting Phase2
A Study of Sacituzumab Govitecan in People With Mesothelioma
📍 Memorial Sloan Kettering Basking Ridge — Basking Ridge, New Jersey
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
Neoadjuvant Durvalumab and Tremelimumab With and Without Chemotherapy for Mesothelioma
📍 Duke Cancer Institute — Durham, North Carolina
View Study & Checklist ➔ 🟢 Recruiting Phase2
MAGIC AKI: Magnesium for the Prevention of HIOC-Associated AKI
📍 Brigham and Women's Hospital — Boston, Massachusetts
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
A 2-part Phase 1/2 Open-label Trial on ODM-212
📍 NEXT Oncology — Irving, Texas
View Study & Checklist ➔